September 19, 2025 · Form 4 insider transaction
RTW INVESTMENTS, LP bought 59,000 shares of Rocket Pharmaceuticals Inc at $17.81 per share, a transaction worth $1.05M. The trade was recorded as exercise of in-the-money option and disclosed on an SEC Form 4, filed 4 days after the transaction.
On September 19, 2025, the equity swap entered into by RTW Innovation Master Fund, Ltd previously reported on the Form 4 filed by the Reporting Persons on December 23, 2022 expired and settled in accordance with its terms. After the transaction reported herein, the amount of Common Stock of the Issuer beneficially owned in the aggregate by the Reporting Persons did not change.; This Form 4 is being filed by each of (i) RTW Investments, LP (the "Adviser") with respect to the securities held by certain investment funds managed by the Adviser (the "RTW Funds") and (ii) Roderick Wong, M.D. ("Dr. Wong"), who serves as the Managing Partner and Chief Investment Officer of the Adviser and who is a director of the Issuer and Chairman of the Issuer's Board of Directors.